1. Home
  2. Companies
  3. New Lantern
NL

New Lantern

About

New Lantern is an AI-native radiology platform founded in 2021. The company provides a single cloud-native workspace that integrates worklist management, PACS viewing, and AI-powered reporting, intended to replace disconnected radiology systems. Its platform currently handles approximately 25% of radiology workflow automation, with a target of 90%, and enables radiologists to achieve a reported +30% RVU growth per year.

The company's product suite includes its AI Radiology Platform and Curie, described as the first and only AI Radiology Resident designed to assist radiologists. Technical domains span artificial intelligence, radiology, medical imaging, cloud-native software, and workflow automation.

New Lantern is headquartered in San Francisco, California, with a presence across the United States. The company raised $19 million in a Series A funding round.

Similar companies

SH

Synthesis Health

Synthesis Health develops a cloud-based radiology imaging platform integrating PACS, AI speech recognition, and workflow automation for radiologists and teleradiology providers in North America.

Rad AI logoRA

Rad AI

Rad AI is a radiologist-led AI company that builds generative AI solutions to automate radiology reporting and follow-up management, helping radiologists save 60+ minutes per day while reducing burnout and improving patient care.

Lunar logoLU

Lunar

Lunar builds the world's first AI-native hospital information system, fundamentally rebuilding hospital information infrastructure to transform clinical and operational workflows.

Lunit logoLU

Lunit

Lunit develops AI-powered diagnostic solutions and platforms that connect imaging, pathology, and biomarker data to improve cancer detection and treatment worldwide.

RA

Radpilot

Radpilot develops AI infrastructure to improve radiology workflows and clinical productivity in healthcare systems.

Proscia logoPR

Proscia

Proscia builds Concentriq, an AI-powered digital pathology platform used by thousands of hospitals and major pharmaceutical companies for cancer discovery and diagnosis.